UroGen Pharma Ltd. (URGN)
9.34
-0.12 (-1.27%)
At close: Mar 03, 2025, 12:26 PM
UroGen Pharma Ltd. Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| PE Ratio | -4.23 | -1.85 | -1.92 | -3.05 | -6.81 | -8.97 | -18.77 | -86.23 | -2.54 | -7.06 | -8.95 |
| PEG Ratio | 0.16 | 0.54 | 0.12 | -0.15 | -3.27 | -0.07 | -0.02 | 0.89 | -0.01 | -0.26 | n/a |
| PS Ratio | 5.23 | 3.14 | 4.42 | 33.26 | 38.06K | 601.40 | 46.02 | 9.55 | n/a | n/a | n/a |
| PB Ratio | -6.63 | -2.28 | 25.26 | 4.07 | 3.80 | 7.53 | 5.48 | 10.26 | 1.98 | 9.28 | 10.80 |
| P/FCF Ratio | -5.65 | -2.3 | -2.48 | -3.66 | -9.6 | -17.9 | -38.15 | 47.90 | -4.31 | -7.77 | -11.32 |
| P/OCF Ratio | -5.66 | -2.31 | -2.5 | -3.71 | -9.65 | -18.17 | -39.23 | 39.96 | -4.49 | -7.81 | -11.57 |
| OCF/S Ratio | -0.92 | -1.36 | -1.77 | -8.97 | -3.95K | -33.1 | -1.17 | 0.24 | n/a | n/a | n/a |
| Debt / Equity Ratio | -1.54 | -1.12 | 0.05 | 0.02 | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a |
| Quick Ratio | 5.24 | 5.21 | 4.90 | 5.30 | 7.63 | 7.59 | 10.54 | 6.99 | 8.55 | 4.81 | 6.50 |
| Current Ratio | 5.42 | 5.39 | 5.11 | 5.39 | 7.63 | 7.59 | 10.59 | 7.03 | 8.55 | 4.81 | 6.50 |
| Asset Turnover | 0.46 | 0.47 | 0.40 | 0.10 | 0.00 | 0.01 | 0.11 | 0.76 | n/a | n/a | n/a |
| Interest Coverage | -4.45 | -9.37 | -5.29 | -355.01 | -385.49 | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | 1.57 | 1.23 | -13.17 | -1.33 | -0.56 | -0.84 | -0.29 | -0.12 | -0.78 | -1.31 | -1.21 |
| Return on Assets (ROA) | -0.57 | -0.8 | -0.93 | -1.05 | -0.5 | -0.73 | -0.26 | -0.08 | -0.65 | -1.05 | -1.03 |
| Return on Capital (ROIC) | -0.45 | -0.7 | -0.95 | -1.26 | -0.6 | -0.86 | -0.29 | 0.04 | -0.72 | -1.26 | -1.24 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 88.68% | 88.11% | 89.27% | 91.45% | 100.00% | -59.84% | 92.65% | 99.84% | n/a | n/a | n/a |
| Net Profit Margin | -123.61% | -169.62% | -230.67% | -1.09K% | -558.5K% | -6.71K% | -245.16% | -11.07% | n/a | n/a | n/a |
| Pretax Profit Margin | -118.87% | -167.86% | -227.66% | -1.06K% | -584.14K% | -6.7K% | -244.93% | -11.07% | n/a | n/a | n/a |
| Operating Profit Margin | -79.23% | -122.82% | -192.11% | -1.07K% | -608.21K% | -6.84K% | -244.55% | 4.55% | n/a | n/a | n/a |
| FCF Margin | -92.57% | -136.45% | -178.27% | -907.71% | -396.34K% | -3.36K% | -120.64% | 19.93% | n/a | n/a | n/a |
| EBITDA Margin | -77.17% | -121.25% | -187.66% | -1.04K% | -600.86K% | -6.84K% | -242.01% | 5.77% | n/a | n/a | n/a |